Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Operating activities
Net loss	$ (12,838)	$ (19,099)
Adjustments to reconcile net loss to net cash used by operating activities
Depreciation and amortization	2,028	2,842
Non-cash interest income	(1)	(118)
Extinguishment of debt	120	0
Change in fair value of warrant liability	23	69
Realized gain on equity investment	(765)	0
Unrealized income on marketable securities	(4)	(12)
Loss on derecognition of intangible assets	251	0
Provision for expected credit losses, net of recoveries	110	56
Provision for expected credit losses on contract assets	(9)	(8)
Stock-based compensation expense	671	201
Changes in assets and liabilities
Accounts receivable	72	(1,760)
Inventories, net	3,616	(1,351)
Prepaid expenses and other current assets	(934)	17,248
Other non-current assets	111	700
Accounts payable	1,207	490
Accrued expenses	175	(18,085)
Deferred revenue	(2,202)	(3,899)
Other current liabilities	61	(463)
Other non-current liabilities	(88)	(55)
Net cash used in operating activities	(8,396)	(23,244)
Investing activities
Purchase of available-for-sale securities	(2,357)	(6,656)
Proceeds from sales and maturities of available-for-sale securities	577	8,307
Proceeds from sale of investment in private company	1,719	0
Purchase of property and equipment	(6)	(77)
Capitalized internally-developed software	(1,528)	(1,098)
Net cash (used in) provided by investing activities	(1,595)	476
Financing activities
Repayment of term loan	(4,777)	(556)
Proceeds from revolving credit facility	4,361	0
Tax withholdings on settlement of equity awards	(116)	0
Net cash used in financing activities	(532)	(556)
Effect of exchange rate on cash	227	(152)
Net change in cash, cash equivalents and restricted cash	(10,296)	(23,476)
Cash, cash equivalents and restricted cash
Beginning of period	34,620	70,203
End of period	24,324	46,727
Supplemental disclosure of non-cash investing and financing activities
Capitalization of stock-based compensation to internally developed software	$ 2	$ 0

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 19,056	$ 34,620
Available-for-sale securities	1,794	0
Accounts receivable, net	7,778	7,960
Inventories, net current	12,099	15,258
Prepaid expenses and other current assets	7,096	7,098
Total current assets	47,823	64,936
Property and equipment, net	775	835
Internally-developed software, net	8,121	8,382
Inventories, net non-current	11,623	12,080
Goodwill	13,605	13,605
Intangible assets, net	1,875	2,297
Other non-current assets	9,625	4,667
Total assets	93,447	106,802
Current liabilities
Accounts payable	5,659	4,447
Current portion of long-term debt	0	1,314
Accrued expenses	10,621	10,458
Deferred revenue, current	11,275	11,237
Other current liabilities	851	790
Total current liabilities	28,406	28,246
Deferred revenue, non-current	12,898	15,138
Long-term debt	4,361	3,330
Other non-current liabilities	2,012	2,077
Total liabilities	47,677	48,791
Commitments and contingencies (see Note 14)
Stockholders' equity
Common stock - $0.0001 par value, 1,000,000,000 shares authorized; 164,860,955 and 163,519,801 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	19	19
Treasury stock	(1)	(1)
Additional paid-in capital	770,980	770,423
Accumulated other comprehensive income	79	39
Accumulated deficit	(725,307)	(712,469)
Total stockholders' equity	45,770	58,011
Total liabilities and stockholders' equity	$ 93,447	$ 106,802